Aspac Iii Acquisition CORP 10-K annual reports
Annual reports — audited financials, the full risk-factor list, and management’s account of the year.
NASDAQ
A SPAC III Acquisition Corp. reports its 2025 annual results, detailing a terminated deal, a new merger agreement with Bioserica, significant shareholder redemptions, and an extended business combination deadline to November 2026.
NASDAQ
A SPAC III Acquisition Corp.'s 10-K filing details its focus on ESG and material technology sectors, potential mergers with HD Group and Bioserica, and associated risks, particularly concerning China-based operations.